Waltham, Massachusetts Clinical Trials

A listing of Waltham, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 116 clinical trials
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

estrogen receptor-positive breast cancer
cancer
estrogen
targeted therapy
breast cancer
Investigational Site Number 8400015
 (8.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +130 other locations
A Multinational Randomized Double-blind Placebo-controlled Study to Assess the Efficacy Pharmacodynamics Pharmacokinetics and Safety of Venglustat in Late-onset GM2

Primary Objectives: Primary population (adult participants with late-onset GM2 gangliosidosis): To assess the efficacy and pharmacodynamics (PD) of daily oral dosing of venglustat when administered over a 104-week period Secondary population (participants with juvenile/adolescent late-onset GM2 gangliosidosis, GM1 gangliosidosis, saposin C deficiency, sialidosis type 1 or juvenile/adult galactosialidosis): To assess …

Investigational Site Number 8400002
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

This study is a multi-center, open-label, dose escalation study of RLY-1971 in subjects with advanced or metastatic solid tumors.

hair thinning
solid tumour
metastatic malignant solid tumor
solid tumor
neuropathy
Dana Farber Cancer Center
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Caterpillar Arterial Embolization Device Post-Market Study

The primary objective of this study is to evaluate the performance and safety of the Caterpillar Arterial Embolization Device when used for arterial embolization in the peripheral vasculature in a real world, on-label application.

Beth Israel Deaconess Medical Center
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations
A Trial of Traffic Light Labeling With Behavioral Nudges and a Healthy Recipe Database to Increase Selection of Healthier Foods in Client-choice Food Pantries

This study is a pilot evaluation of the Healthy Pantry Program, a new behavioral economics-based training that allows pantry staff to learn how to implement nudges integrating traffic-light nutrition labeling and a healthy recipe database in the pantry environment. The hypothesis is that participation the Healthy Pantry Program will lead …

Massachusetts General Hospital
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Treatment of Pregnant Women With OUD

The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)

Beth Israel Deaconess Medical Center
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations
Efficacy of Near-Infrared Vein Imaging for Difficult IV Placement

The objective of this project is to define the effectiveness and therefore the role of NIR vein finders in adult patients with difficult peripheral venous access. The specific objective of the proposed randomized controlled trial is to test the clinical success rate of placing peripheral venous catheters in 'difficult' access …

Lahey Clinic
 (6.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).

cancer
immunohistochemistry
stromal tumor
pdgfra d842v mutation
gilbert's syndrome
Dana Farber Cancer Institute
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

covid-19
blood test
Massachusetts General Hospital
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +10 other locations
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.

stage iv nsclc
cancer
braf v600e mutation
solid tumor
gilbert's syndrome
Massachusetts General Hospital Cancer Center
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations